RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo

BMC Microbiology

Volumn 10, Issue , 2010, Pages

  Zhang, Ya Li ^a   Cheng, Tong ^a   Cai, Yi Jun ^a   Yuan, Quan ^a   Liu, Che ^a   Zhang, Tao ^a   Xia, De Zhen ^a   Li, Rui Yin ^a   Yang, Lian Wei ^a   Wang, Ying Bin ^a   Yeo, Anthony E T ^a   Shih, James Wai Kuo ^a   Zhang, Jun ^a   Xia, Ning Shao ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B(E) ANTIGEN; SHORT HAIRPIN RNA; VIRUS DNA; VIRUS RNA; SMALL INTERFERING RNA; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENOTYPE; HEPATITIS B VIRUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; RNA INTERFERENCE; SCREENING; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECT; GENE THERAPY; GENETICS; HEPATITIS B; HUMAN; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

HEPATITIS B VIRUS; MUS;

ANIMALS; CELL LINE; GENE THERAPY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MICE; MICE, INBRED BALB C; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 77955301529     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-10-214     Document Type: Article

References (43)

1. Hepatitis B virus infection. WM Lee, N Engl J Med 1997 337 24 1733 1745 10.1056/NEJM199712113372406 9392700
2. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. RP Beasley LY Hwang CC Lin CS Chien, Lancet 1981 2 8256 1129 1133 10.1016/S0140-6736(81)90585-7 6118576
3. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. EE Mast MJ Alter HS Margolis, Vaccine 1999 17 13-14 1730 1733 10.1016/S0264-410X(98)00415-0 10194830
4. Clinical toxicity of the interferons. T Vial J Descotes, Drug Saf 1994 10 2 115 150 10.2165/00002018-199410020-00003 7516663
5. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. G Fattovich G Giustina S Favarato A Ruol, J Hepatol 1996 24 1 38 47 10.1016/S0168-8278(96)80184-X 8834023
6. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. YF Liaw, J Hepatol 2009 51 2 403 410 10.1016/j.jhep.2009.04.003 19467727
7. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. A Fire S Xu MK Montgomery SA Kostas SE Driver CC Mello, Nature 1998 391 6669 806 811 10.1038/35888 9486653
8. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. SM Elbashir J Harborth W Lendeckel A Yalcin K Weber T Tuschl, Nature 2001 411 6836 494 498 10.1038/35078107 11373684
9. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. PJ Paddison AA Caudy E Bernstein GJ Hannon DS Conklin, Genes Dev 2002 16 8 948 958 10.1101/gad.981002 11959843
10. RNA interference inhibitors of hepatitis B virus. AP McCaffrey, Ann N Y Acad Sci 2009 1175 15 23 10.1111/j.1749-6632.2009.04974.x 19796073
11. Hepatitis B Virus Inhibition in Mice by Lentiviral Vector Mediated Small Interference RNA. L Deng G Li L Xi A Yin Y Gao W You X Wang B Sun, BMC Gastroenterol 2009 9 1 73 10.1186/1471-230X-9-73 19804649
12. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. PL Yang A Althage J Chung FV Chisari, Proc Natl Acad Sci USA 2002 99 21 13825 13830 10.1073/pnas.202398599 12374864
13. Inhibition of hepatitis B virus in mice by RNA interference. AP McCaffrey H Nakai K Pandey Z Huang FH Salazar H Xu SF Wieland PL Marion MA Kay, Nat Biotechnol 2003 21 6 639 644 10.1038/nbt824 12740585
14. Inhibition of hepatitis B virus expression and replication by RNA interference. A Shlomai Y Shaul, Hepatology 2003 37 4 764 770 10.1053/jhep.2003.50146 12668968
15. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice. RS Ying C Zhu XG Fan N Li XF Tian HB Liu BX Zhang, Antiviral Res 2007 73 1 24 30 10.1016/j.antiviral.2006.05.022 16844238
16. Small interfering RNA inhibits hepatitis B virus replication in mice. H Giladi M Ketzinel-Gilad L Rivkin Y Felig O Nussbaum E Galun, Mol Ther 2003 8 5 769 776 10.1016/S1525-0016(03)00244-2 14599810
17. RNAi for treating hepatitis B viral infection. Y Chen G Cheng RI Mahato, Pharm Res 2008 25 1 72 86 10.1007/s11095-007-9504-0 18074201
18. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. A Ely T Naidoo S Mufamadi C Crowther P Arbuthnot, Mol Ther 2008 16 6 1105 1112 10.1038/mt.2008.82 18431360
19. Possible new hepatitis B virus genotype, southeast Asia. CM Olinger P Jutavijittum JM Hubschen A Yousukh B Samountry T Thammavong K Toriyama CP Muller, Emerg Infect Dis 2008 14 11 1777 1780 10.3201/eid1411.080437 18976569
20. New complex recombinant genotype of hepatitis B virus identified in Vietnam. TT Tran TN Trinh K Abe, J Virol 2008 82 11 5657 5663 10.1128/JVI.02556-07 18353958
21. Detection of a newly identified hepatitis B virus genotype in southeastern France. P Colson B Roquelaure C Tamalet, J Clin Virol 2009 45 2 165 167 10.1016/j.jcv.2009.03.007 19376743
22. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. M Sugiyama Y Tanaka T Kato E Orito K Ito SK Acharya RG Gish A Kramvis T Shimada N Izumi, et al. Hepatology 2006 44 4 915 924 10.1002/hep.21345 17006908
23. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. HL Wu LR Huang CC Huang HL Lai CJ Liu YT Huang YW Hsu CY Lu DS Chen PJ Chen, Gastroenterology 2005 128 3 708 716 10.1053/j.gastro.2004.12.007 15765406
24. RNA-polymerase III-driven expression cassettes in human gene therapy. MF Medina S Joshi, Curr Opin Mol Ther 1999 1 5 580 594 11249665
25. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. D Grimm KL Streetz CL Jopling TA Storm K Pandey CR Davis P Marion F Salazar MA Kay, Nature 2006 441 7092 537 541 10.1038/nature04791 16724069
26. Rational design leads to more potent RNA interference against hepatitis B virus: factors effecting silencing efficiency. K Keck EM Volper RM Spengler DD Long CY Chan Y Ding AP McCaffrey, Mol Ther 2009 17 3 538 547 10.1038/mt.2008.273 19088704
27. Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen. R Bredehorst H von Wulffen C Granato, J Clin Microbiol 1985 21 4 593 598 3988901
28. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA. T Kimura A Rokuhara A Matsumoto S Yagi E Tanaka K Kiyosawa N Maki, J Clin Microbiol 2003 41 5 1901 1906 10.1128/JCM.41.5.1901-1906.2003 12734224
29. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. HL Janssen M van Zonneveld H Senturk S Zeuzem US Akarca Y Cakaloglu C Simon TM So G Gerken RA de Man, et al. Lancet 2005 365 9454 123 129 10.1016/S0140-6736(05)17701-0 15639293
30. [EASL clinical practice guidelines. Management of chronic hepatitis B]. EASL, Gastroenterol Clin Biol 2009 33 6-7 539 554 10.1016/j.gcb.2009.03.002 19481389
31. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy. GV Papatheodoridis S Manolakopoulos, J Hepatol 2009 51 1 226 227 10.1016/j.jhep.2009.02.017 19410321
32. AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy. T Stroffolini GB Gaeta A Mele, Hepatology 2007 46 2 608 609 author reply 609 10.1002/hep.21841 17661422
33. Opportunities for treating chronic hepatitis B and C virus infection using RNA interference. P Arbuthnot V Longshaw T Naidoo MS Weinberg, J Viral Hepat 2007 14 7 447 459 10.1111/j.1365-2893.2006.00818.x 17576386
34. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. MD Moore MJ McGarvey RA Russell BR Cullen MO McClure, J Gene Med 2005 7 7 918 925 10.1002/jgm.739 15756649
35. Short interfering RNA-directed inhibition of hepatitis B virus replication. K Hamasaki K Nakao K Matsumoto T Ichikawa H Ishikawa K Eguchi, FEBS Lett 2003 543 1-3 51 54 10.1016/S0014-5793(03)00400-9 12753904
36. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "i". H Yu Q Yuan SX Ge HY Wang YL Zhang QR Chen J Zhang PJ Chen NS Xia, PLoS One 2010 5 2 9297. 20174575
37. A system for stable expression of short interfering RNAs in mammalian cells. TR Brummelkamp R Bernards R Agami, Science 2002 296 5567 550 553 10.1126/science.1068999 11910072
38. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. T Shiokawa Y Hattori K Kawano Y Ohguchi H Kawakami K Toma Y Maitani, Clin Cancer Res 2005 11 5 2018 2025 10.1158/1078-0432.CCR-04-1129 15756028
39. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. M Ishiyama H Tominaga M Shiga K Sasamoto Y Ohkura K Ueno, Biol Pharm Bull 1996 19 11 1518 1520 8951178
40. Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites. D Sun C Rosler K Kidd-Ljunggren M Nassal, J Hepatol 2010 52 6 817 826 10.1016/j.jhep.2009.10.038 20400195
41. Detection of IFN Response of Non-Specific Effects on RNAi. YG Liang HY Liu BX Liu Y Bai H Wu QH Zhou J Chen, Chin J Lung Cancer 2009 12 1 16 22
42. Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B. SH Wang SH Yeh WH Lin HY Wang DS Chen PJ Chen, Hepatology 2009
43. Replicative competence of the T131I, K141E, and G145R surface variants of hepatitis B Virus. S Jammeh HC Thomas P Karayiannis, J Infect Dis 2007 196 7 1010 1013 10.1086/521198 17763322